Netflix's hugely popular French thriller series Lupin is reportedly returning, but it might not be a season 4. There have ...

Zomato and Jio Financial Services will replace Britannia Industries and Bharat Petroleum Corporation in the Nifty 50, ...

Its renewal should come as no surprise, given that the series remains one of Netflix France’s juggernaut titles. As it stands ...

Indian equities face short-term volatility, but Emkay Institutional Equities predicts the Nifty index will hit 25,000 by ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Corcept Therapeutics Incorporated (NASDAQ:CORT) is a biopharmaceutical company that develops and commercializes therapies ...

The updates are minor but pragmatic and refine the performance and daily use of the Oso with a flush-mounted top tube ...

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...

Two years ago, Lupin Part 3 was premiered on Netflix. The shooting for fourth installment of Lupin is scheduled to start in April 2025, according to WhatsOnNetflix. Creators are yet to confirm whether ...

Here’s how it works. The hit Netflix thriller series Lupin will potentially be returning – but perhaps not in the way fans might have been expecting. The French crime drama became one of ...